Chaoju Eye Care Holdings Limited disclosed that its issued share capital remained unchanged at 705.18 million ordinary shares as of 19 May 2026. No treasury shares are held.

Since 2 April 2026 the company has repurchased, but not yet cancelled, 562,000 shares—equivalent to approximately 0.08 % of the current share count—at prices ranging from HK$2.65 to HK$3.02 per share. The aggregate consideration for these repurchases amounts to about HK$1.61 million.

The latest transaction, executed on 19 May 2026, involved 60,000 shares bought on the Hong Kong Stock Exchange at prices between HK$2.65 and HK$2.68, for a total cost of HK$160,075. All repurchased shares are designated for cancellation.

Under the general mandate approved on 12 May 2026, Chaoju Eye Care is authorised to repurchase up to 70.52 million shares. Repurchases completed to date represent 0.03 % of that mandate. In line with Hong Kong listing rules, the company is subject to a moratorium on new share issues until 18 June 2026.